New findings suggest the addition of 1 mg per day minoxidil to standard lichen planopilaris treatment, while safe, does not result in a significant impact on Lichen Planopilaris Activity Index (LPPAI) or density/thickness of hair.1
These data were authored by a team of investigators led by Mina Saber, from the department of dermatology at Isfahan University of Medical Sciences Skin Diseases and Leishmaniasis Research Center. Saber et al. sought to assess the efficacy and safety of additional low-dose oral minoxidil for patients with lichen planopilaris, a form of alopecia.
Prior data cited by Saber and colleagues have indicated the benefits of topical and low-dose oral minoxidil for maximizing patients’ hair regrowth, especially among individuals who face inherited pattern alopecia.2
“In this randomized controlled…